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Streptococcus mutans and tobacco are risk factors for atherosclerosis. The objective of this study was to 
determine the ability that a spaP isogenic defective mutant of S. mutans UA 159 has on binding to Human 
Umbilical Vein Endothelial Cells (HUVEC) when treated with tobacco products and what second 
messenger signals are involved. The study was conducted to examine the effects that various 
concentrations of cigarette smoke condensate (CSC)- and nicotine have on S. mutans cell cytotoxicity and 
expression of cytokines and growth factors from HUVECs. S. mutans was grown at 37°C and planktonic 
and biofilm cells were separated from the culture supernatant. The supernatant was discarded the cells 
were washed, sterilized with formaldehyde and washed again to remove the formaldehyde. The 
concentrations of the various S. mutans cells were standardized to the same concentration (absorbance of 
0.50 ± 0.01) by spectroscopy at a wavelength of 600 nm. The lowest non-toxic levels of the sterilized 
bacterial cells were used to treat HUVECs for 72 hours and cytotoxicity was determined by lactate 
dehydrogenase (LDH) assays. The cytokine/growth factor expression will be determined by antibody 
protein arrays. The results are expected to indicate an increase in cytotoxicity with increasing cell 
concentrations, along with increased pro-inflammatory cytokine/growth factors expression by the 
HUVECs treated with tobacco treated S. mutans compared to S. mutans that was not treated with tobacco 
products. Second messenger signaling pathways will be analyzed with ERK and JNK inhibitors and 
specific antibodies to ERK and phospho-JNK. Immunoblots using HUVECs will be done to determine 
expression of ERK/JNK. A better understanding of the detrimental effects that tobacco has on the 
underlining causes of atherosclerosis can advance the quest of controlling the disease.  
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